The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The TIME Trial Network to facilitate rapid clinical trial activation, patient screening, and enrollment in molecularly targeted trials.
 
Stephanie OLeary
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Megan Shulman
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Kevin Ritt
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Meghan Degele
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Ewelina Protomastro
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Jennifer Clauson
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Amy Franzen
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - Tempus (Inst)
Travel, Accommodations, Expenses - Tempus
 
Ian Churchill Anderson
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); EMD Serono (Inst); Hutchison MediPharma (Inst); Merck (Inst); Seagen (Inst); Turning Point Therapeutics (Inst)
 
Minal A. Barve
Employment - Texas Oncology
Stock and Other Ownership Interests - Texas Oncology
Research Funding - Mary Crowley Research Center, Dallas Texas
 
David N. Oubre
Leadership - ION Pharma (I)
Stock and Other Ownership Interests - Karyopharm Therapeutics
Consulting or Advisory Role - Cornerstone
Speakers' Bureau - Bayer
Research Funding - AbbVie (Inst); Astellas Pharma (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Celltrion (Inst); FibroGen (Inst); Helsinn Healthcare (Inst); Incyte (Inst); Janssen (Inst); Leap Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Mirati Therapeutics (Inst); MorphoSys (Inst); Natera (Inst); OSE Immunotherapeutics (Inst); Paradigm (Inst); Parker Institute for Cancer Immunotherapy (Inst); Pfizer (Inst); Pharmacyclics (Inst); PrognomIQ (Inst); Spectrum Pharmaceuticals (Inst); Tempus (Inst); TG Therapeutics (Inst)
 
Victor Priego
Research Funding - Aptose Biosciences; ASLAN Pharmaceuticals; BMSi; Celgene; CTI; Incyte; Janssen; Natera; Protagonist Therapeutics; Zeno Pharmaceuticals
 
Angela Saverimuthu
No Relationships to Disclose
 
Francis Mark Senecal
Employment - Northwest Medical Specialties
 
Raju Kumar Vaddepally
Consulting or Advisory Role - Caris MPI
 
Kimberly L. Blackwell
Employment - Lilly; Tempus
Leadership - cereius; Monte Rosa Therapeutics; zentalis
Stock and Other Ownership Interests - Lilly
 
Matthew M. Cooney
Employment - Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - PAREXEL; Tempus